{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:26:08Z","timestamp":1788279968795,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["GSK 214114"],"award-info":[{"award-number":["GSK 214114"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vhri.2024.101001","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T05:49:25Z","timestamp":1717825765000},"page":"101001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study"],"prefix":"10.1016","volume":"43","author":[{"given":"Xin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Gairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Juliao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vhri.2024.101001_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 3","key":"10.1016\/j.vhri.2024.101001_bib2","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","article-title":"Complement and systemic lupus erythematosus","volume":"4","author":"Walport","year":"2002","journal-title":"Arthritis Res"},{"issue":"1","key":"10.1016\/j.vhri.2024.101001_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000484717","article-title":"Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China","volume":"4","author":"Hou","year":"2018","journal-title":"Kidney Dis (Basel)"},{"issue":"3","key":"10.1016\/j.vhri.2024.101001_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1523-1755.2004.00837.x","article-title":"Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.vhri.2024.101001_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2369-15-67","article-title":"Geographical distribution, a risk factor for the incidence of lupus nephritis in China","volume":"15","author":"Pan","year":"2014","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.vhri.2024.101001_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"9","key":"10.1016\/j.vhri.2024.101001_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.vhri.2024.101001_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/rir-2020-0009","article-title":"Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus","volume":"1","author":"Li","year":"2020","journal-title":"Rheumatol Immunol Res"},{"issue":"2","key":"10.1016\/j.vhri.2024.101001_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000430458","article-title":"Lupus nephritis in Asia: clinical features and management","volume":"1","author":"Yap","year":"2015","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"10.1016\/j.vhri.2024.101001_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/acr.20683","article-title":"Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality","volume":"64","author":"Jakes","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.vhri.2024.101001_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.vhri.2024.101001_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/0961203310374305","article-title":"Epidemiology of systemic lupus erythematosus in Asia","volume":"19","author":"Osio-Salido","year":"2010","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.vhri.2024.101001_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40744-021-00368-y","article-title":"The economic burden of lupus nephritis: a systematic literature review","volume":"9","author":"Thompson","year":"2022","journal-title":"Rheumatol Ther"},{"issue":"7","key":"10.1016\/j.vhri.2024.101001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2014.08.066","article-title":"Real world evidence in mainland China: experience with the use of health care claims data","volume":"17","author":"Yang","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2024.101001_bib22","series-title":"Wiley Series on Personality Processes","article-title":"Introduction to the Theory of Nonparametric Statistics","author":"Randles","year":"1979"},{"issue":"Suppl 1","key":"10.1016\/j.vhri.2024.101001_bib23","article-title":"172 The pharmacotherapeutic pattern of lupus nephritis patients and its effect on the hospitalisation cost in China","volume":"4","author":"Li","year":"2017","journal-title":"Lupus Sci Med"},{"issue":"9","key":"10.1016\/j.vhri.2024.101001_bib24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/acr.20502","article-title":"A\u00a0structured literature review of the direct costs of adult systemic lupus erythematosus in the US","volume":"63","author":"Slawsky","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.vhri.2024.101001_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.24545","article-title":"Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large Medicaid population","volume":"61","author":"Li","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.vhri.2024.101001_bib26","article-title":"426 Renal activity and damage incur highest medical costs among Filipino patients with systemic lupus erythematosus","volume":"4","author":"Venegas","year":"2017","journal-title":"Lupus Sci Med"},{"issue":"8","key":"10.1016\/j.vhri.2024.101001_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220800","article-title":"Healthcare costs of patients on different renal replacement modalities - analysis of Dutch health insurance claims data","volume":"14","author":"Mohnen","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vhri.2024.101001_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/kem373","article-title":"SLE patients with renal damage incur higher health care costs","volume":"47","author":"Clarke","year":"2008","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"11","key":"10.1016\/j.vhri.2024.101001_bib29","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.clinthera.2009.11.032","article-title":"Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database","volume":"31","author":"Pelletier","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.vhri.2024.101001_bib30","article-title":"Current status of the evaluation and management of lupus patients and future prospects","volume":"8","author":"Yavuz","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.vhri.2024.101001_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0961203317749746","article-title":"Individuals living with lupus: findings from the LUPUS UK members survey 2014","volume":"27","author":"Morgan","year":"2018","journal-title":"Lupus"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:30:45Z","timestamp":1778848245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109924000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"alternative-id":["S2212109924000347"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101001","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101001"}}